Xencor Earnings
NASDAQ: XNCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.35
Xencor earnings summary
Xencor is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.35. In its most recent report on Aug 5, 2026 (Q2 2026), XNCR posted EPS of $-0.29. Revenue for the quarter was $51.2 million.
Across the last 16 reports, XNCR shares moved an average of 6.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
XNCR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.29 | — | +12.2% |
| May 6, 2026 | — | $-1.71 | — | -12.8% |
| Feb 25, 2026 | — | $-0.09 | — | -11.4% |
| Nov 5, 2025 | — | $-0.08 | — | +7.4% |
| Aug 6, 2025 | — | $-0.41 | — | +6.2% |
| May 7, 2025 | — | $-0.66 | — | -3.2% |
| Feb 27, 2025 | — | $-0.57 | — | -9.7% |
| Nov 6, 2024 | — | $-0.72 | — | -2.3% |
| Aug 5, 2024 | — | $-1.09 | — | +1.2% |
| May 9, 2024 | — | $-1.20 | — | +2.4% |
| Feb 29, 2024 | — | $-0.41 | — | +1.8% |
| Nov 8, 2023 | — | $-0.40 | — | +12.7% |
| Aug 3, 2023 | — | $-0.37 | — | -3.6% |
| May 8, 2023 | — | $-1.02 | — | +2.6% |
| Feb 27, 2023 | — | $-0.20 | — | -15.5% |
| Nov 7, 2022 | — | $-0.55 | — | -1.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.